{"sourcedb":"DevicePMAs@therightstef","sourceid":"P100009_S028","text":"Approval for the MitraClip NT Clip Delivery System and MitraClip NTR/XTR Clip Delivery System for expanding the indication to include secondary mitral regurgitation. The devices, when used with maximally tolerated guideline-directed medical therapy (GDMT), are indicated for the treatment of symptomatic, moderate-to-severe or severe secondary (or functional) mitral regurgitation (MR; MR \u003E= Grade III per American Society of Echocardiography criteria) in patients with a left ventricular ejection fraction (LVEF) \u003E= 20% and \u003C= 50%, and a left ventricular end systolic dimension (LVESD) \u003C= 70 mm whose symptoms and MR severity persist despite maximally tolerated GDMT as determined by a multidisciplinary heart team experienced in the evaluation and treatment of heart failure and mitral valve disease.","project":"consensus_PMA_Age_Indications"}